STOCK TITAN

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
ReWalk Robotics Ltd. rebrands as Lifeward, unveiling a new name, stock ticker, logo, website, and corporate messaging. The company aims to empower individuals facing physical limitations or disabilities by delivering innovative solutions like the AlterG Anti-Gravity systems. The rebrand reflects the broader goal of elevating the standard of care in rehabilitation and driving growth through a unified commercial team. The new stock ticker 'LFWD' will be effective from January 30, 2024.
Positive
  • None.
Negative
  • None.

The rebranding of ReWalk Robotics to Lifeward signifies a strategic shift in the company's market positioning and product portfolio expansion. The integration of the AlterG Anti-Gravity systems, along with existing products like the ReWalk Personal Exoskeleton and the ReStore Exo-Suit, suggests an attempt to capture a larger share of the rehabilitation and assistive technology market. This sector is poised for growth due to an aging population and rising prevalence of chronic diseases leading to physical limitations.

From a market perspective, rebranding can rejuvenate a company's image and attract new customer segments. Lifeward's focus on a broader range of rehabilitation solutions could open up cross-selling opportunities and improve customer retention by offering a more comprehensive suite of products. Additionally, the new stock ticker symbol, LFWD, will align the company's market identity with its brand, potentially aiding in investor recognition and confidence.

However, it's crucial to monitor how the market receives this rebranding effort. The success of such initiatives often depends on the execution of the marketing strategy and the ability to effectively communicate the brand's new value proposition to both clinicians and end-users. Factors such as product efficacy, cost-effectiveness and successful patient outcomes will ultimately drive adoption and sales growth.

ReWalk Robotics' transition to Lifeward introduces several financial considerations. The rebranding process involves significant investment in marketing, new signage, website development and corporate messaging. Investors should evaluate whether these upfront costs are likely to be offset by the anticipated growth in sales and market share. Furthermore, the change in stock ticker to LFWD may attract attention in the short term, but long-term value will depend on the company's financial performance under the new brand.

Analyzing the company's past financials, particularly its R&D spend and sales growth, can provide insights into whether the expanded product portfolio could lead to increased revenue streams. It's also important to assess the competitive landscape, as the assistive technology market is highly innovative with several players. The ability of Lifeward to differentiate itself and demonstrate a clear return on investment for its products will be crucial for sustained financial growth and investor interest.

Rebranding initiatives such as Lifeward's carry legal implications that must be carefully managed. Trademark registrations, protection of intellectual property and compliance with regulatory standards across different jurisdictions are essential to secure the brand's value. The company must ensure that its new name and logo do not infringe on existing trademarks, which could lead to costly legal disputes.

Additionally, the transition to a new stock ticker requires adherence to Nasdaq's rules and regulations. The company must communicate changes effectively to avoid confusion among shareholders and ensure a smooth transition in the market. It is also imperative for the company to update all legal documents, contracts and marketing materials to reflect the new corporate identity, avoiding potential legal pitfalls associated with misrepresentation or outdated information.

Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical limitation or disability

The complete rebrand includes new name, stock ticker, logo, website launch, and corporate messaging


MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 29, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) today unveiled its new corporate branding to officially begin doing business as Lifeward™ (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability.

“With the recent addition of innovative solutions like the AlterG Anti-Gravity systems to our portfolio, we have surpassed the vision of our original name,” said Larry Jasinski, CEO of Lifeward. “The transformation of ReWalk Robotics into Lifeward speaks to the broader goal of the Company to be the driving force to elevate the standard of care in overcoming physical limitations and disabilities to empower individuals to do what they love.”

“Under the Lifeward brand, our newly combined commercial team will represent our full portfolio of solutions as a unified entity,” added Charles Remsberg, Chief Sales Officer at Lifeward. “We believe this will allow us to drive growth for our business through better support of our customers across the rehabilitation spectrum. We have a portfolio of innovative solutions designed to assist individuals in achieving their goals through improved functional and health outcomes – in the clinic as well as in the community.”

Starting today, the Company will begin doing business as Lifeward. Additionally, beginning January 30, 2024, the Company’s ordinary shares will begin trading under the new Nasdaq stock ticker: LFWD. The new corporate website is available at GoLifeward.com and showcases the full portfolio of life-changing solutions, including the ReWalk Personal Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES systems.

To learn more about the new Lifeward identity and mission, please visit GoLifeward.com.

About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES Systems.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward portfolio, please visit GoLifeward.com.

ReWalk®, ReStore®, and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.

Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding Lifeward's future performance and future regulatory interactions and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K and 10-K/A for the year ended December 31, 2022 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Lifeward Media Relations:
LifeSci Communications
E: media@golifeward.com

Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com


FAQ

What is the new name of ReWalk Robotics Ltd.?

The new name of ReWalk Robotics Ltd. is Lifeward.

What is the new stock ticker for Lifeward?

The new stock ticker for Lifeward is LFWD.

What are some of the life-changing solutions offered by Lifeward?

Lifeward offers innovative solutions like the AlterG Anti-Gravity systems, the ReWalk Personal Exoskeleton, the ReStore Exo-Suit, and the MyoCycle FES systems.

When will the new stock ticker 'LFWD' be effective?

The new stock ticker 'LFWD' will be effective from January 30, 2024.

ReWalk Robotics Ltd.

NASDAQ:RWLK

RWLK Rankings

RWLK Latest News

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the